Reconcile
Key product information
Important product information
Review product information, ingredients, storage, warnings, and other important details before ordering.
Overview
Read the product description and usage details.
Overview
Reconcile® Chewable Tablets contain fluoxetine hydrochloride in a flavoured, chewable tablet. It is indicated for the treatment of canine separation anxiety in conjunction with a behaviour modification plan.
Product Details
| DIN (Drug Identification Number) | 02307960 |
| Active Ingredients | fluoxetine hydrochloride in a flavoured, chewable tablet |
| Approved For | Dog |
| Therapeutic Use | Antidepressant |
| Form | Chewable tablet |
| Route of Administration | Oral |
| Strength / Concentration | 16 mg mg |
| Pack Size | 30 Chewable Tablets |
Safety & Storage
Storage: Ambient
Specifications
Review available public product specifications and handling details.
Basic Information
| Brand | Virbac |
|---|---|
| DIN | 2307960, 2307979, 2307987, 2307952 |
| Active Ingredient | fluoxetine hydrochloride in a flavoured, chewable tablet |
| Strength | 16 mg, 32 mg, 64 mg, 8 mg |
| Pack Size | 30 Chewable Tablets |
Storage & Shipping
| Storage Conditions | Ambient |
|---|
Important Notice
Product information is provided for reference only and does not replace veterinary advice. Always follow your veterinarian’s direction for prescription products.